Methacrylic Acid

Methacrylic Acid

SCHEMBL472593

C=C(C)C(=O)O.OCC(CO)CO

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 1/20 0.45
TDP1 Q9NUW8 1/20 0.36
TSHR P16473 1/20 0.34
OR51E2 Q9H255 2/20 0.33
TET2 Q6N021 4/20 0.32
TET3 O43151 1/20 0.32
TET1 Q8NFU7 1/20 0.32
ALDH1A1 P00352 1/20 0.32
FFAR3 O14843 1/20 0.32
LCK P06239 1/20 0.32
FYN P06241 1/20 0.32
GRIK1 P39086 1/20 0.31
GRIK2 Q13002 1/20 0.31
GRM1 Q13255 1/20 0.31
GRM2 Q14416 1/20 0.31
KDM4E B2RXH2 1/20 0.30
MAPT P10636 1/20 0.30
THRB P10828 1/20 0.30
ALOX15 P16050 1/20 0.30
NFKB1 P19838 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methacrylic Acid SCHEMBL5595699 1.00 TGFBR1 (0.45) TGFBR1TDP1TSHROR51E2TET2
Methacrylic Acid SCHEMBL147269 1.00 TGFBR1 (0.45) TGFBR1TDP1TSHROR51E2TET2
Methacrylic Acid SCHEMBL9815885 1.00 TGFBR1 (0.45) TGFBR1TDP1TSHROR51E2TET2
Methacrylic Acid SCHEMBL3974705 0.87 TGFBR1 (0.41) TGFBR1TDP1TSHRALDH1A1
Methacrylic Acid SCHEMBL1480102 0.87 TGFBR1 (0.41) TGFBR1TDP1TSHRALDH1A1
Methacrylic Acid SCHEMBL4158756 0.87 TGFBR1 (0.41) TGFBR1TDP1TSHRALDH1A1
Methacrylic Acid SCHEMBL514764 0.87 TGFBR1 (0.41) TGFBR1TDP1TSHRALDH1A1
Methacrylic Acid SCHEMBL2032735 0.85 TGFBR1 (0.39) TGFBR1TDP1TSHR
Methacrylic Acid SCHEMBL8383578 0.85 TGFBR1 (0.39) TGFBR1TDP1TSHR
Methacrylic Acid SCHEMBL51594 0.85 TGFBR1 (0.39) TGFBR1TDP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11872292-B2 Cationically and radiation curable composition 3M INNOVATIVE PROPERTIES COMPANY (US) 2024-01-16 US disclosed
US-20230320941-A1 DENTAL COMPOSITION, KIT AND METHOD FOR USE AS ALTERNATIVE RESTORATIVE MATERIAL TO DENTAL AMALGAM SDI LIMITED (AU) 2023-10-12 US disclosed
EP-4196077-A1 DENTAL COMPOSITION, KIT AND METHOD FOR USE AS ALTERNATIVE RESTORATIVE MATERIAL TO DENTAL AMALGAM Sdi Limited (AU) 2023-06-21 EP disclosed
US-20230175067-A1 PROGNOSIS METHOD FOR RENAL CELL CANCER NATIONAL CANCER CENTER (JP) 2023-06-08 US disclosed
EP-3346015-B1 PROGNOSIS METHOD FOR RENAL CELL CANCER NAT CANCER CT (JP) 2022-05-11 EP disclosed
WO-2022032351-A1 DENTAL COMPOSITION, KIT AND METHOD FOR USE AS ALTERNATIVE RESTORATIVE MATERIAL TO DENTAL AMALGAM SDI LIMITED (AU) 2022-02-17 WO disclosed
US-20220047465-A1 DENTAL COMPOSITION GC CORPORATION (JP) 2022-02-17 US disclosed
EP-3515396-B1 CATIONICALLY AND RADIATION CURABLE COMPOSITION 3M INNOVATIVE PROPERTIES CO (US) 2022-01-05 EP disclosed
US-11142801-B2 Tumor determination method JAPANESE FOUNDATION FOR CANCER RESEARCH (JP) 2021-10-12 US disclosed
US-20210276243-A1 THREE-DIMENSIONAL PRINTING COMPOSITION AND METHOD OF PRODUCING DENTAL ARTICLE GC CORPORATION (JP) 2021-09-09 US disclosed
WO-2006084769-A1 CARBOXYLIC ACID CONTAINING DISPERSANTS FOR COMPOSITES DENTSPLY DETREY GMBH (DE) 2006-08-17 WO disclosed
EP-1498098-B1 Adhesive composition with decreased polarity upon polymerization 3M ESPE AG (DE) 2006-05-03 EP disclosed
US-20060069181-A1 Dental adhesive composition 3M ESPE AG 2006-03-30 US disclosed
EP-1639987-A1 Dental adhesive composition 3M Espe AG (DE) 2006-03-29 EP disclosed
WO-2005004819-A1 ADHESIVE COMPOSITION WITH DECREASED POLARITY UPON POLYMERIZATION 3M ESPE AG (DE) 2005-01-20 WO disclosed
EP-1498098-A1 Adhesive composition with decreased polarity upon polymerization 3M ESPE AG (DE) 2005-01-19 EP disclosed
EP-0948955-B1 POLYMERIZABLE DENTAL COMPOSITION KURARAY CO (JP) 2003-09-03 EP disclosed
US-6191191-B1 USED AS BONDING AGENT, COMPOSITE RESIN, ADHESIVE AGENT, PRIMER AND OPAQUE PRIMER FOR DENTAL USE; LIGHT RESISTANCE; ADHESION TO TOOTH SURFACE AND METALS; COLORFASTNESS KURARAY CO., LTD. (JP) 2001-02-20 US disclosed
EP-0948955-A1 POLYMERIZABLE DENTAL COMPOSITION KURARAY CO., LTD. (JP) 1999-10-13 EP disclosed
US-4838789-A EXTERIOR SHIELD AND PHOTOPOLYMERIZABLE RESIN G-C DENTAL INDUSTRIAL CORP. (JP) 1989-06-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11872292-B2 Cationically and radiation curable composition RAD51, SMARCA1, SMARCA4 TGFBR1 606/4885TDP1 665/4885TSHR 4421/4885
US-20220047465-A1 DENTAL COMPOSITION TAS2R45, TAS2R40, TAS2R42 TGFBR1 4638/4885TDP1 527/4885TSHR 3246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.